Rayca Precision

Rayca Is A Breakthrough In Precision Oncology and Clinical Research

About Rayca Precision

Rayca Precision, founded in late 2021, has a mission to deal with cancer diseases and empower individuals to lead longer and healthier lives. The company aims to achieve this goal by reinventing, designing, and implementing cutting-edge technologies in translational and clinical medicine to systematically treat and monitor cancer.

Utilizing precision oncology, Rayca Precision strives to assist oncologists manage cancer innovatively, providing cancer patients with care tailored to their affliction, biological profile, and characteristics. The company intends to leverage Artificial Intelligence and high-throughput transcriptome and genome profiling to monitor cancer from its earliest stages and develop the most optimal treatment plan to improve patient survival rates.

Aside from cancer-specific analytical solutions for clinical research, Rayca Precision also aims to assist biotech and pharma in transferring therapeutic solutions to clinical trials more effectively.

Our Team of Professionals

At Rayca Precision, we work together to drive scientific discovery and translate it into meaningful advancements in cancer treatment. Our team members bring unique perspectives and experiences to the table, allowing us to approach problems from different angles and devise innovative solutions. We are committed to fostering a collaborative and supportive work environment where everyone’s ideas are valued and respected.

Pouya Behrouzi

Co-Founder & CEO

Mahdi Muhaddesi

Co-Founder and VP of Compliance & Infrastructure

Mahmood Zali

Co-Founder & VP of Business Development

Piero Palacios Bernuy

Bioinformatician Scientist

Carlos Eduardo

Bioinformatician Intern

Merav Leveson

Machine Learning Engineer

Anna Smith


Clinical Data Scientist

David Rizzo

Medical Sales Representative

Michael P. Krasevic

Medical Sales Representative

Paul Beltran

Medical Sales Representative

Dean Massee

Medical Sales Representative